Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

2 Aug 2021 07:00

RNS Number : 1378H
Chesnara PLC
02 August 2021
Β 

CHESNARA plc

("Chesnara" or "the Company")

Β 

02 August 2021

Β 

LEI Number: 213800VFRMBRTSZ3SJ06

Β 

Β 

CHESNARA PLC CHANGE OF DIRECTORSHIP

and REMUNERATION ARRANGEMENTS FOR CEO-ELECT

Β 

On 12 May 2021, Chesnara announced that John Deane intended to retire from the Company and to step down as Group Chief Executive by the end of the year. Chesnara also announced that it had identified Steve Murray as intended successor to the role of Group Chief Executive.

Β 

Steve Murray has today been appointed an Executive Director of Chesnara and Countrywide Assured plc. Upon securing regulatory approval, he will become Chesnara's Group Chief Executive.

Β 

Steve held a number of awards under the various incentive plans of his previous employer, The Royal London Mutual Insurance Society, and replacement awards will be granted upon his appointment as Group Chief Executive in line with Chesnara's Remuneration Policy.

- A cash payment will be made to Steve upon appointment to compensate for the value of his 2018 Royal London STIP which was forfeited on cessation.

- He will be granted buy-outs of other Royal London awards using the approved Chesnara Long Term Incentive- and Short Term Incentive- schemes. Steve's 2021 Royal London STIP will be met through the Chesnara Short Term Incentive Scheme, with 65% to be paid in cash to the extent it vests in April 2022 and 35% as share options deferred in line with the scheme. In the case of the Royal London long term incentives, the Chesnara grants will be struck at the closing price on the day that his regulatory approval is received. Should Chesnara be in a Closed Period at that time, these grants will be struck at the closing price of the first day's trading after that Closed Period comes to an end.

Β 

Full disclosure of these remuneration arrangements will be provided in the Directors' Remuneration Report to be published in 2022.

Β 

For further information, please contact:

Β 

Β 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

Β 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.ukΒ 

Β 

Β 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

Β 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

Β 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 16 years in succession.

Β 

Further details are available on the Company's websiteΒ (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOARMMATMTAJBIB
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.